Close
Almac
Achema middle east

Production & Manufacturing

4 Trends Transforming the Never-Normal Future of Manufacturing

2021 Manufacturing Trends If 2020 was the year of disruption, 2021 is the year of adaptation. Download this trend brief to explore ways that manufacturers are adapting to change and evolving to stay competitive. What's Included: Embracing digitization. Liberating data. Balancing...

CapsCanada Launches Liquid-Filled Hard Capsule Manufacturing Service in North America

CapsCanada, a Lyfe Group company and leader in capsule technology for over three decades, is pleased to announce the launch of a new liquid-filled hard capsule manufacturing service. CapsCanada’s objective is to support the entire manufacturing process, from formulation...

PsiVac and Lonza Enter a Strategic Agreement for the Process Development and cGMP Manufacturing of Ixovex-1

PsiVac, a subsidiary of Ixogen; a UK biotechnology research and development company focused on the development of new therapeutic cancer treatments for solid tumors, and Lonza, a world leader in contract manufacturing, announced their agreement for the process development...

Altimmune Expands AdCOVID Manufacturing Collaboration with Lonza

Altimmune, Inc., a clinical-stage biopharmaceutical company, announced that it has expanded its previously-announced AdCOVID™ manufacturing collaboration with Lonza. Under the expanded agreement, Lonza will commission a dedicated manufacturing suite for clinical and commercial production of AdCOVID, Altimmune’s single-dose intranasal...

Jubilant HollisterStier Signs Manufacturing Agreement with Eli Lilly for COVID-19 Therapeutic Bamlanivimab

Jubilant Life Sciences Ltd, an integrated global Pharmaceuticals and Life Sciences Company, recently announced that its wholly-owned subsidiary, Jubilant Pharma Limited, through one of its subsidiaries, Jubilant HollisterStier LLC , has signed new contract with Eli Lilly for contract...

Recipharm signs manufacturing agreement with Enzymatica

Recipharm, a leading contract development and manufacturing organisation (CDMO) and Enzymatica, a Swedish life science company specialising in products with a protective barrier, have signed a broadened contract for the manufacture of ColdZyme®. The agreement will involve an additional Recipharm...

Oxgene introduces TESSA technology for plasmid-free manufacturing system for Adeno-associated virus

Oxgene, a biotechnology company designing and developing scalable gene therapy technologies, has announced the launch of its scalable, plasmid-free manufacturing system for Adeno-associated virus (AAV). Oxgene’s new TESSA technology addresses industry-wide challenges associated with robust and reproducible AAV manufacture...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »